Get access

Mast cells in the promotion and limitation of chronic inflammation

Authors

  • Martin Metz,

    1. Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA.
    Search for more papers by this author
  • Michele A. Grimbaldeston,

    1. Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA.
    Search for more papers by this author
  • Susumu Nakae,

    1. Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA.
    2. Department of Allergy and Immunology, National Research Council for Child Health & Development, Tokyo, Japan.
    Search for more papers by this author
  • Adrian M. Piliponsky,

    1. Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA.
    Search for more papers by this author
  • Mindy Tsai,

    1. Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA.
    Search for more papers by this author
  • Stephen J. Galli

    Corresponding author
    1. Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA.
    2. Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA, USA.
      Stephen J. Galli
      Department of Pathology, L-235
      Stanford University School of Medicine
      300 Pasteur Drive
      Stanford, CA 94305-5324, USA
      Tel.: +1 650 723 7975
      Fax: +1 650 725 6902
      E-mail: sgalli@stanford.edu
    Search for more papers by this author

Stephen J. Galli
Department of Pathology, L-235
Stanford University School of Medicine
300 Pasteur Drive
Stanford, CA 94305-5324, USA
Tel.: +1 650 723 7975
Fax: +1 650 725 6902
E-mail: sgalli@stanford.edu

Abstract

Summary:  Observations of increased numbers of mast cells at sites of chronic inflammation have been reported for over a hundred years. Light and electron microscopic evidence of mast cell activation at such sites, taken together with the known functions of the diverse mediators, cytokines, and growth factors that can be secreted by appropriately activated mast cells, have suggested a wide range of possible functions for mast cells in promoting (or suppressing) many features of chronic inflammation. Similarly, these and other lines of evidence have implicated mast cells in a variety of adaptive or pathological responses that are associated with persistent inflammation at the affected sites. Definitively characterizing the importance of mast cells in chronic inflammation in humans is difficult. However, mice that genetically lack mast cells, especially those which can undergo engraftment with wildtype or genetically altered mast cells, provide a means to investigate the importance of mast cells and specific mast cell functions or products in diverse models of chronic inflammation. Such work has confirmed that mast cells can significantly influence multiple features of chronic inflammatory responses, through diverse effects that can either promote or, perhaps more surprisingly, suppress aspects of these responses.

Get access to the full text of this article

Ancillary